A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.

The genetic risk factors for chronic obstructive pulmonary disease (COPD) are still largely unknown. To date, genome-wide association studies (GWASs) of limited size have identified several novel risk loci for COPD at CHRNA3/CHRNA5/IREB2, HHIP and FAM13A; additional loci may be identified through larger studies. We performed a GWAS using a total of 3499 cases and 1922 control subjects from four cohorts: the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE); the Normative Aging Study (NAS) and National Emphysema Treatment Trial (NETT); Bergen, Norway (GenKOLS); and the COPDGene study. Genotyping was performed on Illumina platforms with additional markers imputed using 1000 Genomes data; results were summarized using fixed-effect meta-analysis. We identified a new genome-wide significant locus on chromosome 19q13 (rs7937, OR = 0.74, P = 2.9 × 10(-9)). Genotyping this single nucleotide polymorphism (SNP) and another nearby SNP in linkage disequilibrium (rs2604894) in 2859 subjects from the family-based International COPD Genetics Network study (ICGN) demonstrated supportive evidence for association for COPD (P = 0.28 and 0.11 for rs7937 and rs2604894), pre-bronchodilator FEV(1) (P = 0.08 and 0.04) and severe (GOLD 3&4) COPD (P = 0.09 and 0.017). This region includes RAB4B, EGLN2, MIA and CYP2A6, and has previously been identified in association with cigarette smoking behavior.

[1]  Per Magne Ueland,et al.  Genetic Polymorphisms in 15q25 and 19q13 Loci, Cotinine Levels, and Risk of Lung Cancer in EPIC , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[2]  L. Bierut,et al.  The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European–Americans , 2011, Pharmacogenetics and genomics.

[3]  P. Sham,et al.  Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.

[4]  Genome-wide association study of smoking behaviours in patients with COPD , 2011, Thorax.

[5]  Eleazar Eskin,et al.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.

[6]  D. Postma,et al.  Opportunities and Challenges in the Genetics of COPD 2010: An International COPD Genetics Conference Report , 2011, COPD.

[7]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[8]  K. Morgan,et al.  The role of IREB2 and transforming growth factor beta-1 genetic variants in COPD: a replication case-control study , 2011, BMC Medical Genetics.

[9]  G. Gamble,et al.  Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD , 2011, PloS one.

[10]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[11]  G. Gamble,et al.  Chromosome 4q31 locus in COPD is also associated with lung cancer , 2010, European Respiratory Journal.

[12]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[13]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[14]  William Wheeler,et al.  Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD , 2010, PLoS genetics.

[15]  Christopher I. Amos,et al.  Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5‐A3 genetic locus and lung cancer risk , 2010, Cancer.

[16]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[17]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[18]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[19]  C. Gieger,et al.  Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior , 2010, Nature Genetics.

[20]  Ming D. Li,et al.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.

[21]  C. Hersh.  Faculty Opinions recommendation of Genome-wide association study identifies five loci associated with lung function. , 2010 .

[22]  A. Gulsvik,et al.  Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? , 2010, The clinical respiratory journal.

[23]  Marc Decramer,et al.  The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. , 2010, American journal of respiratory and critical care medicine.

[24]  Christoph Lange,et al.  Variants in FAM13A are associated with chronic obstructive pulmonary disease , 2010, Nature Genetics.

[25]  A. Hofman,et al.  Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study , 2009, European Respiratory Journal.

[26]  Byron C. Wallace,et al.  The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. , 2009, Human molecular genetics.

[27]  K. Holland,et al.  Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. , 2009, American journal of human genetics.

[28]  E. Silverman,et al.  Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. , 2009, American journal of human genetics.

[29]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[30]  R. Tyndale,et al.  A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo , 2009, The Pharmacogenomics Journal.

[31]  D. Mannino,et al.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.

[32]  H. O'brodovich,et al.  Global and gene-specific translational regulation in rat lung development. , 2009, American journal of respiratory cell and molecular biology.

[33]  K. Shianna,et al.  A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.

[34]  Scott T. Weiss,et al.  A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study , 2009, PLoS genetics.

[35]  Andrew D. Johnson,et al.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..

[36]  Maarit Tiirikainen,et al.  Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. , 2008, Cancer research.

[37]  G. Gamble,et al.  Lung cancer gene associated with COPD: triple whammy or possible confounding effect? , 2008, European Respiratory Journal.

[38]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[39]  Yasutaka Nakano,et al.  Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[40]  R. Tyndale,et al.  Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent , 2008, Human mutation.

[41]  A. Bosserhoff,et al.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. , 2008, Developmental biology.

[42]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[43]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[44]  S. Hurd,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[45]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[46]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[47]  Y. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[48]  M. Post,et al.  Hypoxia-inducible Factors in the First Trimester Human Lung , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  C. Strange,et al.  Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency , 2007, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[50]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[51]  J Vestbo,et al.  Developing COPD: a 25 year follow up study of the general population , 2006, Thorax.

[52]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[53]  Thomas A Trikalinos,et al.  Family-Based versus Unrelated Case-Control Designs for Genetic Associations , 2006, PLoS genetics.

[54]  D. DeMeo,et al.  Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[55]  Edwin K Silverman,et al.  The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. , 2006, American journal of respiratory and critical care medicine.

[56]  E. Silverman,et al.  A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease. , 2005, American journal of respiratory cell and molecular biology.

[57]  N. Laird,et al.  Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. , 2005, American journal of respiratory cell and molecular biology.

[58]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[59]  Aravinda Chakravarti,et al.  Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies , 2004, Nature Genetics.

[60]  Christoph Lange,et al.  PBAT: tools for family-based association studies. , 2004, American journal of human genetics.

[61]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[62]  E. Silverman,et al.  Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. , 2003, Human molecular genetics.

[63]  J. Otte,et al.  Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.

[64]  E. Silverman,et al.  Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. , 2002, Human molecular genetics.

[65]  E. Silverman.  Genetic Epidemiology of COPD. , 2002, Chest.

[66]  J. Twisk,et al.  Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years. , 2001, Addiction.

[67]  N J Wareham,et al.  Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. , 2001, American journal of respiratory and critical care medicine.

[68]  R. Tyndale,et al.  Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. , 2000, Molecular pharmacology.

[69]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[70]  A. Buist,et al.  Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. , 1999, The American journal of medicine.

[71]  G. Coetzee,et al.  Genetic variation of CYP2A6, smoking, and risk of cancer , 1999, The Lancet.

[72]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[73]  N. Caporaso,et al.  Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. , 1997, Addictive behaviors.

[74]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[75]  Y. Funae,et al.  Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. , 1996, The Journal of pharmacology and experimental therapeutics.

[76]  E. Arnesen,et al.  Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. , 1996, Circulation.

[77]  W. Bailey,et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.

[78]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[79]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[80]  M. Lebowitz,et al.  Quantitative relationships between cigarette smoking and ventilatory function. , 1977, The American review of respiratory disease.

[81]  Albert Damon,et al.  The Normative Aging Study: An Interdisciplinary and Longitudinal Study of Health and Aging , 1972 .

[82]  R. K. Larson,et al.  The familial occurrence of chronic obstructive pulmonary disease. , 1965, Annals of internal medicine.

[83]  Hervé Dumez,et al.  Vancouver , 1960 .

[84]  A. Hofman,et al.  Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function , 2010, Nature Genetics.

[85]  S. Hurd,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[86]  张锺儒,et al.  对急性哮喘加剧的成年患者两种不同教育干预的评价[英]／Co^^té J…∥Am J Respir Crit Care Med , 2002 .

[87]  C. Laurell,et al.  The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .